T1	Participants 42 103	patients with atrial fibrillation undergoing cardiac surgery.
T2	Participants 239 272	atrial fibrillation (AF) patients
T3	Participants 428 477	One hundred and fifty patients with documented AF
T4	Participants 548 630	One hundred and thirty-two patients were included in the cost-effectiveness study.
